NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

FeMike, I think the disconnect here is that you are making a NWBO share price prediction within 3 to 6 months, after DCVax-L approval in the U.K. only.

However, most NWBO longs here are basing their valuation projections more long-term, after regulatory approvals in the US, Canada, UK, Germany and the rest of the EU. The U.K. only does not have an addressable GBM market of 12,000 patients per year, but the U.K., plus Germany, plus the rest of the EU, does have an addressable GBM market (nGBM + rGBM) of at least 12,000 patients per year.

I don’t believe most NWBO longs here are planning to sell all or most of their NWBO shares in the next 3 to 6 months.